期刊文献+

微淋巴管密度与乳腺浸润性导管癌淋巴结转移的相关性研究 被引量:4

Study of the Relationship between the Microlymphatic Density and Lymph Node Metastasis in Breast Invasive Ductal Carcinoma
下载PDF
导出
摘要 目的探讨正常乳腺组织、乳腺浸润性导管癌组织内部、癌周围组织中微淋巴管密度(MLD)及其与相关病理参数之间的关系,分析浸润性导管癌淋巴结转移的可能机制。方法应用免疫组化S-P法检测以上三种组织中MLD。结果癌周围组织中MLD明显高于癌组织内部(P<0.05)和正常乳腺组织(P<0.05)。癌周围组织中MLD与组织学分级、淋巴结转移密切相关(P<0.05),而与患者的年龄、肿瘤的大小无关(P>0.05)。结论浸润性导管癌周围组织中MLD与淋巴结转移密切相关,是预测浸润性导管癌淋巴结转移的有效指标之一,有助于判断浸润性导管癌的预后。 Objective To investigate the density of lymphatic vessel in three kinds of breast tissles and the correlation between microlymphatic density(MLD)and traditional clinicopathological parameter,analyse the possible mechanism of lymph node metastasis in breast invasive ductal carcinoma.Methods The expression of D2-40 in three kinds of breast tissles was detected by immunohistochemical S-P method,by which the MLD was calculated.Results The peritumoral MLD was significantly higher than that intratumoral MLD(P0.05)and that in normal breast tissue(P0.05).There was a positive correlation of peritumoral MLD with lymph node metastasis and histological grade(P0.05),there was no statiatical significance between different size of tumor and age(P0.05).Conclusion There was close relationship between the peritumoral MLD and lymph node metastasis and invision,it can be use as a marker to evaluate the lymph node metastasis and measure the prognosis of breast invasive ductal carcinoma.
出处 《医学综述》 2011年第8期1246-1249,共4页 Medical Recapitulate
关键词 乳腺浸润性导管癌 微淋巴管密度 淋巴结转移 Breast invasive ductal carcinoma Microlymphatic density Lymph node metastasis
  • 相关文献

参考文献12

  • 1El-Gohary YM,Silverman JS,Olson PR,et al.Endoglin(CD105)and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma[J].Am J Clin Pathol,2007,127(4):572-579.
  • 2Saad RS,Kordunsky L,Denning KL,et al.Lymphatic microvessel density as prognostic marker in colorectal carcinoma[J].Mod Pathol,2006,19(10):1317-1323.
  • 3Fogt F,Zimmerman RL,Ross HM,et al.Identification of lymphatic vessels in malignant,adenomatous and normal colonic mucosa using the novel immunostain D2-40[J].Oncol Rep,2004,11(1):47-50.
  • 4Jackson DG.The lymphatics revisited:new perspectives from the hyaluronan receptor LYVE-1[J].Trends Cardiovasc Med,2003,13(1):1-7.
  • 5Agarwal B,Saxena R,Morimiya A,et al.Lymphangiogenesis does not occur in breast cancer[J].Am J Surg Pathol,2005,29(11):1449-1455.
  • 6Arnaout-Alkarain A,Kahn HJ,Narod SA,et al.Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer[J].Mod Pathol,2007,20(2):183-191.
  • 7Van der Auwera I,van Laere SJ,van den Eynden GG,et al.Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification[J].Clin Cancer Res,2004,10(23):7965-7971.
  • 8Valencak J,Heere-RessE,KoppT,et al.Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessel in patient with malignant melanoma[J].Eur J Carcinoma,2004,40(3):358-364.
  • 9Atsuo shida,MD,Shuichi fujioka,MD.Prognostic significance of vascular endothelial growth factor D in gastric carcinoma[J].World J Surg,2005,29(12):1600-1607.
  • 10El-Gohary YM,Metwally G,Saad RS,et al.Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas[J].Am J Clin Pathol,2008,129(4):578-586.

同被引文献29

  • 1马捷,孙国平.p53基因与乳腺癌的相关性[J].医学综述,2005,11(2):112-113. 被引量:6
  • 2方义湖,黄琼,邓红,徐芳英,吕炳建,来茂德.微淋巴管和微血管密度对结直肠癌的预后意义[J].临床与实验病理学杂志,2007,23(1):17-20. 被引量:7
  • 3Pulitzer M,Desman G, Busam KJ. CK7 expression in primary cutaneous squamous cell carcinoma[J]. Journal of Cutaneous Pathology, 2010,37 (9) : 966-972.
  • 4Yasuoka H, Kodama R, Himkawa M, et al. NeumpiLin-2 expression in papillmy thyrroid eareinomu:cnrrehlion with VEGF-D expres- sion, lymph node metastasis, and VEGF-D-indueed aggressive cancer cell phenotype [ J ]. J Clin Endeerinol Metab, 2011,96 (11) :E1857 -61.
  • 5Saad R S, Kordunsky L, Liu Y L, et al. Lymphatic microvessel density as prognostic marker in colorectal cancer[ J]. Mod Pathol, 2006,19(10) :1317 -23.
  • 6Soong R, Shah N, Peh B K, et al. The expression of RUNX3 in colorectal cancer is bassociated with disease stage and patient out- come [ J ]. Br J Cancer,2009,100 ( 5 ) :676 - 9.
  • 7He Y, Rajantie I, IImonen M, et al. Preexisting lymphatic endothe- lium but not endothlial progenifor cells are essential for tumor lym- phaogenesis and lymphatic metastasis [ J ]. Cancer Res, 2004,64 (11) :3737 -40.
  • 8Kozhlwski M, Naumnik W, Niklifiski J, et al. lymphatic vessel inva- sion detected by the endothelial lymphatic marker D2-40 ( podopla- nin) is predictive of regional Iymph node status and an independ- ent prognostic factor in patients with reseeted esophageal cancer [ J ]. Folia Histochem Cytobil, 2011,49 ( 1 ) : 90 - 7.
  • 9Longatto Filho A, OIiveira T G, Pinheiro C, et al. How useful is the assessment of Lymphatic vascular density in oral carcinoma progno- sis? [J]. World J Surg Oneol,2007 ,5 :140.
  • 10Ito K. RUNX3 in oncogentic and anti-oncogenic signaling in gastro- intestinal cancers [ J ]. J Cell Bioehem,2011,112 (5) : 1243 - 9.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部